Lofibra 134 mg Gate 323 (Lofibra 134 mg)

Generic Name: fenofibrate

Pill with imprint Lofibra 134 mg Gate 323 is Blue, Capsule-shape and has been identified as Lofibra 134 mg. It is supplied by Gate Pharmaceuticals.

Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 134 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Lofibra 134 mg Gate 323

Save up to 80% off prescription medications

Click here for your free Discount Card

Lofibra

Generic Name:

fenofibrate

Imprint:

Lofibra 134 mg Gate 323

Strength:

134 mg

Color:

Blue

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Fibric acid derivatives

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Gate Pharmaceuticals

Inactive Ingredients:

croscarmellose sodium
crospovidone
lactose monohydrate
magnesium stearate
povidone k25
corn starch
sodium lauryl sulfate
D&C Red No. 28
FD&C Blue No. 1
titanium dioxide
gelatin
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.